论文部分内容阅读
冠心病是威胁人类健康和生命的重要疾病之一。经研究证明血胆固醇水平增高,与冠心病发病有因果关系。降低高胆固醇症,可减少冠心病的危险性。因此,选择一种安全有效的降血脂药物是非常重要的。总结如下。 1 资料及方法 1.1 病例选择 30例符合高脂血症诊断标准的住院患者(按卫生部药政局颁发的“心血管系统药物临床研究指导原则”为标准)随机分为三组:观察组、对照Ⅰ组和对照Ⅱ组。观察组10例,年龄:52～74岁,平均60.8岁,其中40～49岁1例,50～59岁2例,60～69岁5例,70～79岁2例,男8例,女2例。对照Ⅰ组10例,年龄55～72岁,平均64.3岁,其中40～49岁3例,50～59岁2例,60～69岁4例,70～79岁1例,男8例,女2例。对照Ⅱ组10例,年龄42～72岁,平均56.6岁,其中40～49岁3例,50～59岁2例,60～69岁4例,70～79岁1例,男4例,女6例。
Coronary heart disease is one of the important diseases threatening human health and life. After studies have shown that elevated blood cholesterol levels, and causal relationship between the incidence of coronary heart disease. Reduce high cholesterol, can reduce the risk of coronary heart disease. Therefore, the choice of a safe and effective lipid-lowering drugs is very important. Summarized as follows. 1 Materials and Methods 1.1 Case Selection 30 cases of patients with diagnostic criteria for hyperlipidemia in line with the “guidelines for clinical research of cardiovascular system drugs” issued by the State Council’s Pharmaceutical Administration of the Ministry of Health as a standard) were randomly divided into three groups: the observation group, control Ⅰ group and control Ⅱ group. The observation group consisted of 10 patients aged 52-74 years with an average of 60.8 years old, including 40 cases of 49 cases in 1 case, 50 cases of 59 cases in 2 cases, 60 cases of 69 cases in 5 cases, 70 cases of 79 cases in 2 cases, 8 males and 8 females 2 cases. Control group Ⅰ 10 cases, aged 55 to 72 years, an average of 64.3 years, of which 40 to 49 years in 3 cases, 50 to 59 years in 2 cases, 60 to 69 years in 4 cases, 70 to 79 years in 1 case, 8 males and 8 females 2 cases. Control Ⅱ group 10 cases, aged 42 to 72 years, mean 56.6 years, of which 40 to 49 years in 3 cases, 50 to 59 years in 2 cases, 60 to 69 years in 4 cases, 70 to 79 years in 1 case, 4 males and females 6 cases.